FDA PMA FDA Class 3 Approved 🇺🇸 United States

Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer

PMA: P000021 · Supplement: S015 · Decision May 27, 2010
Classifications
1
FEI Numbers
15
Registration Numbers
15

Basic Information

Device Name
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Trade Name
DIMENSION TPSA FLEX REAGENT CARTRIDGE
PMA Number
P000021
Supplement Number
S015
Device Class
FDA Class 3
Product Code
MTF
Generic Name
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Medical Specialty
Unknown
Advisory Committee
Immunology
Decision
Approved
Decision Code
APPR
Decision Date
May 27, 2010
Date Received
May 19, 2009
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE DIMENSION TPSA FLEX REAGENT CARTRIDGE ON THE DIMENSION EXL WITH LM SYSTEM.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MTF Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer